Almanac A1C

Rethinking Saturated Fat: Why Decades of Dietary Dogma May Need a Modern Makeover

Posted

by

A1C Medical Writer 2

Table of Contents
Keywords: , , , , , ,

Introduction

The relationship between saturated fat intake and cardiovascular health has stood at the center of dietary guidelines for decades. Traditional recommendations, catalysed by early epidemiological findings and randomized trials, have consistently advised limiting saturated fat to reduce cardiovascular disease (CVD) risk, primarily through its effect on lowering low-density lipoprotein cholesterol (LDL-C) [1-3]. These policies influenced both public health strategy and clinical practice, shaping food industry standards worldwide.

Yet in recent years, a surge of contemporary evidence- particularly from randomized controlled trials (RCTs) and meta-analyses-has begun to challenge this long-held paradigm. A growing number of studies now report that reducing saturated fat intake does not significantly impact cardiovascular or all-cause mortality [4]. Some meta-analyses even suggest neutral or beneficial effects of certain saturated fat-rich foods, such as whole-fat dairy or unprocessed meats, on heart health, questioning the utility of universal saturated fat restrictions [5,6]. Furthermore, the nature of the replacement nutrient-be it polyunsaturated fats, monounsaturated fats, or carbohydrates- appears pivotal in determining health outcomes, with replacement by refined carbohydrates showing little to no benefit [1,6].

This evolving body of evidence calls for a critical re-evaluation of traditional dietary guidelines regarding saturated fat. In this article, we dissect recent RCTs and systematic reviews to explore whether a blanket restriction on saturated fat remains scientifically justified, or whether nuanced, food-based recommendations would better serve public cardiovascular health.

Keywords: saturated fatty acids, cardiovascular disease, mortality, systematic review, meta-analysis, dietary intervention

Contemporary Evidence from Randomized Controlled Trials

Methodological Considerations in Recent Meta-Analyses

Recent high-quality meta-analyses on saturated fat restriction and cardiovascular disease (CVD) outcomes have focused keenly on methodological rigor:

  • Study inclusion: Most recent umbrella reviews and systematic reviews prioritize randomized controlled trials (RCTs) but also consider large cohort studies for context, Strict criteria are used regarding participant demographics, intervention duration (typically 2+years), dietary assessment reliability, and verified cardiovascular endpoints [7,8].
  • Risk of Bias and Quality Grading: Studies are evaluated using tools like GRADE or AMSTAR-2, grading the certainty of evidence as high, moderate, or low based on risk of bias, indirectness, imprecision, and publication bias[7-9].
  • Comparators and Outcomes: Analyses often differentiate between replacements of saturated fat with polyunsaturated fat, monounsaturated fat, or carbohydrates, acknowledging the importance of the replacement nutrient in determining cardiovascular outcomes [7].
  • Heterogeneity: The presence of heterogeneity is evaluated, and meta-regression or subgroup analyses are used to explore sources (e.g., degree of fat reduction, participant baseline risk, replacement macronutrient), which helps clarify conflicting findings across studies.[8,9]
  • Reporting of Combined Cardiovascular Events: There is an increasing focus on “combined cardiovascular events” as a primary endpoint, aggregating outcomes such as myocardial infarction, stroke, and coronary heart disease occurrences to improve statistical power and clinical relevance [7,8].

Primary Findings from High-Quality Meta-Analysis

  • Reduction in Combined Cardiovascular Events: Multiple recent meta-analyses, including updated Cochrane reviews and large umbrella reviews, consistently show that reducing saturated fat intake for at least two years leads to a modest but significant reduction in the risk of combined cardiovascular events (RR ≈ 0.79, 95%CI: 0.66-0.93; moderate-quality evidence), translating to a 215 risk reduction [7-9].
  • No Significant Effect on Mortality: Despite the reduction in nonfatal CVD events, there is little or no effect on all-cause or cardiovascular mortality, cancer mortality, or diabetes incidence [7,8].
  • Number Needed to Treat (NNT): In primary prevention trials, about 56 individuals need to reduce saturated fat intake over four years to prevent one cardiovascular event. The benefit is somewhat greater in secondary prevention trials (NNT≈32) [8,9].
  • Replacement Nutrient Matters: There is clear benefit when saturated fat is replaced by polyunsaturated fat; benefits are less clear when replaced by carbohydrates (especially refined), with very limited data for monounsaturated fat or protein [8]
  • Individual Risk Factors: There is no strong evidence that the effect differs by sex, baseline cholesterol, or baseline cardiovascular risk [8,9].

Evidence for Combined Cardiovascular Events

  • Meta-analyses of RCTs consistently report a statistically significant reduction in combined cardiovascular events (including myocardial infarction, stroke, and other major events) when saturated fat is reduced, with no significant harm from such dietary changes [7-9].
  • Magnitude of Effect: The pooled relative risk suggest a reduction of about 21%, with moderate certainty due to heterogeneity and potential limitations such as adherence and follow-up duration [7,8].
  • Consistency Across Reviews: These findings are echoed in umbrella reviews and systematic reviews published in recent years, reinforcing the robust nature of the effect for combined cardiovascular events, even if mortality effects are negligible [7-9].

So in summary, contemporary evidence from recent RCT meta-analyses demonstrates that reducing saturated fat intake produces a meaningful reduction in combined cardiovascular events but does not alter overall or cardiovascular-specific mortality. Methodically robust studies highlight the need for precise nutrient replacements and long-term intervention follow-up- the benefits are most pronounced when saturated fats are replaced with polyunsaturated fats rather than with refined carbohydrates. These findings challenge but also refine previous dietary paradigms, advocating for targeted modification of saturated fat intake within the broader context of macronutrient substitution [7-9].

Mechanistic Considerations and Biological Plausibility

Lipoprotein Subfraction Analysis

Advances in lipoprotein measurement have highlighted important nuances in the cholesterol-lowering effects of saturated fat restriction. Traditional dietary advice emphasizes saturated fat’s ability to raise low-density lipoprotein cholesterol (LDL-C), but contemporary evidence shows that the nature of LDL particles matters greatly. Saturated fat tends to raise large, buoyant LDL particles, which are considered relatively less atherogenic compared to small, dense LDL particles that more efficiently penetrate the arterial wall and are more strongly associated with cardiovascular disease (CVD) risk [10-12].

Recent randomized controlled trials and detailed lipid subfraction analyses illustrate that saturated fat restriction preferentially lowers large LDL particles, resulting in a moderate reduction in total LDL-C, but may have little effects or even increase the proportion of small, dense LDL particles if saturated fat is replaced with refined carbohydrates [10,11]. This findings puts into question the straightforward benefit of saturated fat reduction and highlights why not all LDL-C changes translate directly into altered CVD risk. Furthermore, some studies have found that saturated fat reduction can increase levels of lipoprotein(a) [Lp(a)], another lipoprotein fraction associated with elevated CVD risk, particularly if the replacement macronutrients are carbohydrates or omega-6-rich polyunsaturated fats [12].

Contemporary Metabolic Effects

The metabolic consequences of saturated fat intake depend not only on the amount consumed but more crucially on the overall dietary context, particularly the nature of macronutrient replacement. Recent metabolic ward studies and isotopic tracer analyses indicate that replacing saturated fat with polyunsaturated fats (especially omega-3-rich fatty acids) improves serum lipid profiles, reduces inflammation markers, and confers clear cardiovascular benefits [13,14]. Conversely, substituting saturated fat with refined carbohydrates fails to improve-and may sometimes worsen-lipid subfractions by raising triglycerides and increasing small dense LDL particles, both of which promote atherogenesis and metabolic dysfunction [13,15].

Importantly, research has shown that increases in circulating saturated fatty acids often arise from excess carbohydrate intake and hepatic de novo lipogenesis, rather than directly from dietary saturated fat[13,15].. This indicates that metabolic derangements attributed to “high-saturated-fat diets” may sometimes reflect broader diet quality and carbohydrate excess, rather than the saturated fat content per se. Thus, metabolic effects are context-specific and can differ greatly according to individual insulin sensitivity, replacement macronutrient, and overall dietary pattern.

Clinical Context and Contemporary Medical Practice

Statin Era Considerations

Since the 1990s, the widespread adoption of statins has fundamentally transformed cardiovascular disease (CVD) management. Statins are now the first-line pharmaceutical intervention for lowering low-density lipoprotein cholesterol (LDL-C), with robust evidence from numerous randomized controlled trials demonstrating significant reductions in both primary and secondary CVD events, mortality, and the need for revascularization [16,17]. In clinical practice, statins are prescribed to over 25% adults above 40 years in the United States, illustrating their integration into routine care [17]. Contemporary guidelines stress targeting both cholesterol reduction and, in some cases, residual inflammatory risk that may persist despite optimal statin therapy [18].

Importantly, the dominance of statins in reducing CVD risk has shifted the relative importance of dietary management, including saturated fat restriction, especially for those on these medications., While dietary interventions remain foundational to public health, the added benefit attributable specifically to saturated fat reduction may be attenuated in statin-treated populations. Nonetheless, diet remains crucial for individuals who cannot tolerate statins, those at borderline risk, or who prefer non-pharmacological approaches [1,19].

Population Considerations

Current dietary guidelines reflect evidence that CVD risk and benefit from saturated fat restriction are not uniform across all populations. The impact of saturated fat reduction is most pronounce in individuals with established hypercholesterolemia, metabolic syndrome, diabetes, or clinical ASCVD-groups in which restriction is specifically emphasized by leading guidelines (e.g., recommendations to limit saturated fat to 5-6% of total energy intake for high-risk individuals) [1,19].

Meanwhile, the effects of dietary interventions may differ according to baseline socioeconomic factors, ethnicity, and access to healthcare. For example, statin therapy benefit are well-established for middle -aged adults but evidence base in older adults (especially those over 75) is limited, creating uncertainty about the balance of benefits and risks in this cohort [20,21]. Cultural dietary patterns also influence baseline saturated fat intake and practical ability to make recommended dietary changes.

Gender Considerations

Sex-based differences are increasingly recognized in CVD epidemiology and dietary response. While most earlier studies predominantly included male participants, more recent evidence suggests that women often present with responses [22,23]. For instance, women with coronary artery disease are more likely to present with obesity, diabetes, and hypertension, and their dietary fat intake may differ from men, potentially influencing risk modification strategies [23]. However, intervention trial reveal that both men and women generally experience similar lipid profile changes in response to variations in dietary fat, and when differences occur, they lack a clear, consistent pattern [22].

Emerging research also points to possible gender-specific interactions between nutrient intake (such as dietary fiber and saturated fat) and cardiovascular outcomes, but the findings remain inconsistent and warrant further study [24].

Contemporary Practice

In modern clinical settings, dietary recommendations for CVD prevention have shifted towards a holistic, food-based approach. Emphasis is placed on increasing intake of plant-based foods, whole grains, fruits, and vegetables while minimizing processed foods, excessive saturated and trans fats, and refined sugars [25,26]. The Mediterranean and DASH diets exemplify this paradigm and are widely recommended by professional societies. Implementation often requires multidisciplinary care and consideration of barriers such as socioeconomic status, access, and cultural context [25].

Ultimately, in the statin era, a personalized, population-informed, and gender-sensitive approach to dietary management-complementing pharmacological therapy-remains essential to optimizing cardiovascular outcomes in diverse patient populations.

Alternative Dietary Approaches and Whole Food Patterns

Mediterranean Diet Evidence

The Mediterranean diet (MedDiet) is one of the most extensively studied and supported dietary patterns for cardiovascular disease (CVD) prevention. This diet emphasizes high intakes of minimally processed plant-based foods (vegetables, fruits, legumes, whole grains, and nuts), olive oil as the primary fat source, moderate consumption of fish and poultry, low intake of red and processed meats, and modest intake of dairy and wine [27-29].

Robust evidence, including meta-analyses and randomized controlled trials, supports the cardio-protective effects of the MedDiet. For primary prevention, the landmark PREDIMED trial found that adults at high cardiovascular risk who followed a MedDiet experienced a significant reduction in major cardiovascular events compared to those on a standard low-fat diet [27,29]. Observational cohorts and pooled analyses consistently show that greater adherence to the MedDiet correlates with reduced rates of coronary heart disease, ischemic stroke, and overall cardiovascular mortality [28,29]. Mechanisms include anti-inflammatory effects, improvements in lipid and glycaemic profiles, microbiome diversity, and reduction of traditional risk factors [27,29,30].

Whole Food Dietary Patterns

Contemporary research has shifted from single-nutrient to whole food-based approaches, recognizing that the combination and quality of foods in a dietary pattern exert a synergistic influence on health outcomes [31,32]. Diets abundant in whole grains, fruits, vegetables, legumes, nuts, and healthy fats are repeatedly shown to lower CVD risk, while Western patterns high in red and processed meats, sugar, and ultra-processed foods are linked to increased risk [32,33].

American Heart Association (AHA) Contemporary Guidance

The American Heart Association (AHA) 2021 guidance recommends adopting overall healthy dietary patterns rather than focusing on single nutrients. Key features include [31,34,35]:

  • High intake of fruits and vegetables (varied and deeply coloured)
  • Emphasis on whole grains over refined grains
  • Preference for plant-based protein (legumes and nuts), fish, and seafood; if consuming meat or dairy, choose lean and low-fat options
  • Use of liquid plant oils (such as olive oil) instead of animal fats or tropical oils
  • Selection of minimally processed and low-sodium foods
  • Minimal consumption of added sugars
  • Mindful alcohol consumption (if any)
  • Adherence to these habits regardless of food preparation location
  • Recommendation of dietary patterns such as the Mediterranean, DASH, and healthy vegetarian diets- all shown to reduce CVD risk.

The AHA also cautions against restrictive fat diets, such as very low carbohydrate or very low fat diets, unless medically indicated, due to concerns about nutrient sufficiency, long-term adherence and alignment with heart health priorities [34].

In summary a growing consensus affirms that Mediterranean and other whole food dietary patterns, rich in plant-based foods, healthy oils, and minimally processed items, are effective strategies for reducing cardiovascular risk. The AHA’s contemporary guidance reflects this evidence, emphasizing diverse, balanced, and predominantly plant-based diets to optimize cardiovascular health and prevent disease.

Implications for Clinical Practice and Public Health Policy

Reassessment of Current Guidelines

Emerging evidence from large-scale randomized controlled trials and meta-analyses has challenged the traditional paradigm that strictly limiting saturated fat intake is critical for cardiovascular disease (CVD) prevention [5,6,36]. Recent reviews show that the association between saturated fat intake and risk of CVD or mortality is less clear-cut than previously believed, with some types of whole foods rich in saturated fat-such as whole fat dairy, unprocessed meats, and dark chocolate-not linked to increased CVD or diabetes risk [5,37]. Moreover, the health impact of saturated fat varies significantly depending on the food matrix and the nutrient replacing it in the diet [1,5].

The insights suggest that rigid population-wide caps (such as limiting saturated fat to less than 10% of daily calories), which underpin many current guidelines in the US and globally, may not be fully supported by the latest scientific evidence [5,6,36]. In fact, policy recommendations to reduce saturated fat intake are often based on surrogate markers (like LDL-cholesterol) rather than direct clinical endpoints, and they may overlook the broader dietary context, such as overall food quality and patterns [5,6]. As a result, the focus is shifting from single—nutrient target to holistic, food-based recommendations that consider the type and source of fats, the overall dietary pattern, and individual risk profiles [1,5,37].

Clinical Practice

For clinicians, these developments imply a more nuanced approach to dietary counselling. Rather than advocating for blanket saturated fat restriction, practitioners are encouraged to focus on:

  • The quality and source of dietary fats (favouring unsaturated fats over saturated fats primarily when found in processed foods), while recognizing that not all saturated fat-rich foods are inherently harmful [5].
  • The context of the whole diet, encouraging food patterns such as the Mediterranean or DASH diets, which emphasize plant-based foods, healthy oils, and minimally processed items [1,37].
  • Tailoring advice according to patient-specific risk factors and concurrent therapies (for example, acknowledging a potentially smaller added benefit of saturated fat restriction for patients already on potent statin therapy) [5,6].

Public Health Policy

From a policy standpoint, there is growing support for updating dietary guidelines to reflect the diversity of evidence [5,6,36]. This may mean:

  • Moving away from strict, universal caps on saturated fat and toward recommendations that prioritize whole foods and overall dietary patterns [5,6].
  • Supporting individualized nutrition counselling that accounts for cultural, socioeconomic, and personal health factors [6,36].
  • Ensuring public health messages do not inadvertently stigmatize or confuse consumers about specific food groups, but instead encourage balanced diets composed of minimally processed ingredients [5,37].

Future Research Priorities

Emerging evidence underscores several key areas for future research on saturated fat and cardiovascular health:

  • Food Matrix and Sources: More investigation is needed to differentiate the cardiovascular effects of saturated fats according to their food sources (e.g., dairy vs. meat) and to understand the impact of the broader food matrix in which saturated fat is consumed [38,39].
  • Replacement Nutrients: research should better clarify how substituting saturated fat with specific macronutrients-such as various types of unsaturated fats or whole vs, refined carbohydrates-affects cardiovascular outcomes long term [5,39,40].
  • Individual Biological Responses: There is a need to explore genetic and metabolic factors that may influence individual responses to dietary saturated fat, including the effects on different lipoprotein subfractions and cardiometabolic risk markers beyond LDL cholesterol (like apolipoprotein B and lipoprotein(a)) [5,39,42].
  • Population Diversity: Future studies should more thoroughly evaluate effects across diverse populations, considering age, sex, ethnicity, and comorbid conditions, to inform personalized dietary guidelines [38,39].
  • Dietary Patterns and Sustainability: Research should focus on the effect of whole dietary patterns not just isolated nutrients, as well as issues sustainability and cultural appropriateness [38,43].
  • Hard Clinical Endpoints: Additional randomized controlled trials with longer follow-up are crucial to assess outcomes like cardiovascular events and mortality rather than relying primarily on surrogate endpoints (e.g., changes in cholesterol levels) [8,39,40].

Clinical Decision-Making Considerations

Contemporary clinical decision-making now emphasizes a personalized and food-based approach:

  • Individualization: clinical guidelines increasingly recommend tailoring dietary advice to individual risk profiles, dietary preferences, metabolic responses, and social or cultural contexts.
  • Replacement emphasis: rather than blanker saturated fat restriction, practitioners are advised to focus on what replaces saturated fat in the diet, favoring the substitution of saturated fat with unsaturated fats (especially polyunsaturated fats) rather than refined carbohydrates [39,44].
  • Practical Counselling: Clinicians should guide patients toward dietary patterns shown to reduce cardiovascular risk- such as Mediterranean or DASH diets-while considering factors like feasibility, sustainability, and nutrient adequacy [2,31,43].
  • Addressing Gaps and Uncertainty: Guidelines should acknowledge existing uncertainties- particularly concerning the impact of saturated fats from different food matrices and in various subpopulations -and keep recommendations updated as new evidence emerges [38,43].

In summary, integrating a nuanced understanding of dietary fats into clinical and public health practice demands ongoing research attention toward food-based, culturally tailored, and individualized nutrition, along with stronger trial evidence on clinically relevant outcomes [5,38,39].

Limitations and Methodological Considerations in Dietary Trials

Inherent Challenges in Dietary Trials

Randomized controlled trials (RCTs) in nutrition face unique methodological obstacles that complicate both the conduct of the studies and the interpretation of their outcomes. Key challenges include:

  • Compliance and Adherence: Participants may not consistently follow assigned diets over long periods, introducing variability and diminishing observed intervention effects [45,46].
  • Blinding Difficulties: Unlike pharmaceutical trials, it is hard to blind participants and researchers to dietary interventions, risking expectancy and performance bias [45,47].
  • Measurement Error: Assessing actual dietary intake relies on self-report methods (food diaries, recalls0 that are prone to under or overestimation and recall bias [47,48].
  • Collinearity of Foods and Nutrients: Foods contain mixtures of nutrients and bioactives, making it difficult to attribute observed effects to a single nutrient (like saturated fat) independent of the food matrix or other dietary factors [45,46].
  • Population Heterogeneity: Baseline diet, cultural practices, and genetic background can vary widely among participants, influencing how dietary interventions work across groups and limiting generalizability [45,48].

Temporal and Contextual Limitations

The temporal and contextual nature of dietary exposures introduces further complexity:

  • Short Study Durations: Many trials last only months to few years, whereas cardiovascular disease develops over decades, which limits the ability to detect long-term effects of dietary changes [4,48].
  • Changes in Medical Practice: Evolving standards, such as widespread statin use or shifting dietary habits over time, can mask or modify the effect of dietary interventions relative to older studies [4,12].
  • Socioeconomic and Environmental Contexts: Access to foods, cultural dietary preferences, and the “real-world” food environment (including food availability, cost, and time constraints) affect both what diets can be implemented and their potential benefits at the population level [48,49].
  • Temporal Spatiobehavioral Variability: The places and times people procure and consume food are variable and do not always match researchers’ assumptions or area-based data collection, making it challenging to accurately assess true dietary exposure and its relation to health outcome over time [49].

In summary interpreting evidence from dietary trials requires careful consideration of these methodological and contextual limitations. Recognizing these challenges is crucial for designing more robust future studies and for making appropriate public health recommendations regarding saturated fat and cardiovascular risk [45,46,47,48,49].

Future Directions and Research Needs

Contemporary Trial Design

Advances in nutrition science and the mixed results from past studies have highlighted the need for more rigorous, innovative trial designs to clarify the relationship between saturated fat and cardiovascular health. Future trials should:

  • Prioritize large-scale, multi-arm randomized controlled trial designs, which capture complex dietary exposures and allow for meaningful comparisons of multiple dietary interventions within the same trial population [50].
  • Incorporate adaptive designs, which can optimize intervention strategies in real time based on interim results, increase study efficiency, and address challenges unique to nutrition research, such as small effect sizes and large inter-individual variability [51].
  • Leverage behavioural and support methodologies to enhance participant adherence, such as technology-based monitoring, real-world setting interventions, and personalized feedback, recognizing that participant compliance remains a significant cofounding factor in dietary studies [52].
  • Utilized objective biomarkers, advanced dietary tracking tools, and long-term follow-up to minimize bias and better capture the real-life impact of dietary changes on hard cardiovascular endpoints [50,52,53].

Regulatory and Policy Implications

New research is driving policy makers and regulatory bodies to reassess longstanding dietary fat guidelines:

  • There is a growing recognition of the need to tailor saturated fat recommendations based on food source, the overall dietary pattern, and population-specific risk profiles, rather than maintaining rigid, one-size-fits-all upper limits on saturated fat intake [5,6,54].
  • Policy development should be more tightly aligned with evidence from well-conducted contemporary randomized controlled trials rather than relying heavily on surrogate endpoints, observational data, or outdated paradigms [6].
  • Future regulatory actions may increasingly encourage food manufacturers to improve the quality of their products-such as reformulating ultra-processed foods, reducing industrial trans fats, and promoting transparent labelling-rather than focusing solely on reducing saturated fat content [55].
  • Updated policies should better address the diversity of global populations, cultural dietary practices, and food environments, ensuring new guidelines are both scientifically grounded and practical to implement worldwide [54].

In summary, progress in this field will arise from more rigorous, contextually aware clinical trials and a move toward nuanced, evidence-based regulations. Such approaches are essential to produce meaningful, actionable guidance for both public health and clinical practice as our understanding of dietary fats and cardiovascular risk continues to evolve [50,51,53,55].

Conclusion

Recent evidence from high-quality randomized controlled trials and meta-analyses challenges traditional dietary guidance that universally restricts saturated fat intake to prevent cardiovascular disease. The relationship between saturated fat and cardiovascular risk is now understood to be more nuanced, with health outcomes highly dependent on the food source and the nutrient replacing saturated fat in the diet. While substituting saturated fat with polyunsaturated fats appears beneficial, replacement with refined carbohydrates or certain other nutrients shows little or no advantage. Moreover, the advent of widespread statin use, the recognition of individual and population diversity, and advances in whole-food dietary pattern research highlight the need for more personalized and food-focused recommendations. Future dietary guidelines should move beyond rigid single-nutrient targets, embracing holistic, evidence-based patterns that prioritize overall diet quality and account for the broader context of individual and public health. Ongoing research and innovation in trial design will be essential to refine these recommendations and inform policy, ensuring cardiovascular prevention strategies remain both effective and adaptable to evolving scientific insight.

References

  1. Sacks FM, Lichtenstein AH, Wu JHY, Appel LJ, Creager MA, Kris-Etherton PM, et al. Dietary fats and cardiovascular disease: A presidential advisory from the American heart association. Circulation [Internet]. 2017 Jun 15;136(3):e1–23. Available from: https://www.ahajournals.org/doi/10.1161/cir.0000000000000510
  2. American Heart Association. Saturated Fat [Internet]. American Heart Association. 2024. Available from: https://www.heart.org/en/healthy-living/healthy-eating/eat-smart/fats/saturated-fats
  3. World Health Organization. WHO updates guidelines on fats and carbohydrates [Internet]. www.who.int. 2023. Available from: https://www.who.int/news/item/17-07-2023-who-updates-guidelines-on-fats-and-carbohydrates
  4. Saturated Fat Restriction for Cardiovascular Disease Prevention: A Systematic Review and Meta-analysis of Randomized Controlled Trials. JMA Journal. 2025 Jan 1;8(2).
  5. Astrup A, Magkos F, Bier DM, Brenna JT, de Oliveira Otto MC, Hill JO, et al. Saturated Fats and Health: A Reassessment and Proposal for Food-based Recommendations: JACC State-of -the-Art Review. Journal of the American College of Cardiology [Internet]. 2020 Jun 17;76(7). Available from: https://www.sciencedirect.com/science/article/pii/S0735109720356874?via%3Dihub&fbclid=IwAR04U10WUTUjvwepa5HNedoOSM5LyKx2tVnJS0d6FQpIIYESDQcrtrDjXgk
  6. Astrup A, Teicholz N, Magkos F, Bier DM, Brenna JT, King JC, et al. Dietary Saturated Fats and Health: Are the U.S. Guidelines Evidence-Based? Nutrients [Internet]. 2021 Oct 1;13(10):3305. Available from: https://www.mdpi.com/2072-6643/13/10/3305
  7. Aramburu A, Gandy Dolores-Maldonado, Curi-Quinto K, Cueva K, Giancarlo Alvarado-Gamarra, Alcalá-Marcos K, et al. Effect of reducing saturated fat intake on cardiovascular disease in adults: an umbrella review. Frontiers in Public Health. 2024 Jun 3;12.
  8. Hooper L, Martin N, Jimoh OF, Kirk C, Foster E, Abdelhamid AS. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database of Systematic Reviews [Internet]. 2020 May 19;5(5). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388853/
  9. Bell AE, Culp PA. Reduction in Saturated Fat Intake for Cardiovascular Disease. American Family Physician [Internet]. 2022 Jan 1;105(1):online–online. Available from: https://www.aafp.org/pubs/afp/issues/2022/0100/od2.html
  10. Bergenon N, Chiu S, Williams PT, M King S, Krauss RM. Effects of saturated fatty acids on LDL particle size and concentration and other cardiometabolic risk factors: a randomized controlled trial. Am J Clin Nutri. 2015;102(6)0:1502-1515
  11. Mensink RP. Effects of saturated fatty acids on serum lipids and lipoproteins: a systematic review and regression analysis. World Health Organization; 2016
  12. Astrup A, Magkos F, Bier DM, Brenna JT, de Oliveira otto MC, Hill JO, et al. Saturated fats and health: a reassessment and proposal for food-based recommendations. J Am Coll Cardiol. 2020;76(7):844-857.
  13. Imamura F, Micha Rm Wu JH, de Oliveira Otto MC, Otite FO, Abioye Al, et al. Effects of saturated fat, polyunsaturated fat, monounsaturated fat, and carbohydrate on glucose-insulin homeostasis: a systematic review and meta-analysis of randomized controlled feeding trials. PLoS Med. 2010;7(3):e1000252
  14. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review 2010;7(3):e1000252.
  15. ‌Stanhope KL, Bremer AA, Medici V, Nakajima K, Ito Y, Nakano T, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2011;119(5):1322-1334
  16. Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews [Internet]. 2013 Jan 31;1(1). Available from: https://www.cochrane.org/CD004816/VASC_statins-primary-prevention-cardiovascular-disease
  17. Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL, Goldstein LB, et al. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology. 2019 Feb;39(2).
  18. Liuzzo G, Patrono C. Targeting residual cardiovascular risk in the statin era: cholesterol or inflammation? European heart journal [Internet]. 2023 Sep;44(22):1973–5. Available from: https://pubmed.ncbi.nlm.nih.gov/37138427/
  19. Maki KC, Dicklin MR, Kirkpatrick CF. Saturated fats and cardiovascular health: Current evidence and controversies. Journal of Clinical Lipidology [Internet]. 2021 Oct;15(6):765–72. Available from: https://pubmed.ncbi.nlm.nih.gov/34649831/
  20. Virani SS. Statins and Primary Atherosclerotic Cardiovascular Disease Prevention—What We Know, Where We Need to Go, and Why Are We Not There Already? JAMA Network Open. 2022 Aug 23;5(8):e2228538.
  21. Saeed A, Mehta L. Statin Therapy in Older Adults for Primary Prevention of Atherosclerotic Cardiovascular Disease: The Balancing Act [Internet]. American College of Cardiology. 2020. Available from: https://www.acc.org/latest-in-cardiology/articles/2020/10/01/11/39/statin-therapy-in-older-adults-for-primary-prevention-of-atherosclerotic-cv-disease
  22. Lapointe A, Balk EM, Lichtenstein AH. Gender differences in plasma lipid response to dietary fat. Nutrition Reviews. 2006 May 1;64(5 Pt 1):234–49.
  23. Najafi M, Mehrdad Sheikhvatan. Gender Differences in Coronary Artery Disease: Correlational Study on Dietary Pattern and Known Cardiovascular Risk Factors. International Cardiovascular Research Journal [Internet]. 2013 Dec [cited 2025 Jul 30];7(4):124. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3987447/
  24. Wallström P, Sonestedt E, Hlebowicz J, Ericson U, Drake I, Persson M, et al. Dietary Fiber and Saturated Fat Intake Associations with Cardiovascular Disease Differ by Sex in the Malmö Diet and Cancer Cohort: A Prospective Study. Obukhov AG, editor. PLoS ONE. 2012 Feb 27;7(2):e31637.
  25. Diab A, Dastmalchi LN, Gulati M, Michos ED. A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now? Vascular Health and Risk Management. 2023 Apr 21;19(19):237–53.
  26. Marques-Vidal P, Tsampasian V, Cassidy A, Biondi-Zoccai G, Chrysohoou C, Koskinas K, et al. Diet and nutrition in cardiovascular disease prevention: a scientific statement of the European Association of Preventive Cardiology and the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology. European Journal of Preventive Cardiology [Internet]. 2025 Jun 12 [cited 2025 Jul 25]; Available from: https://doi.org/10.1093/eurjpc/zwaf310
  27. Pant A, Chew DP, Mamas MA, Zaman S. Cardiovascular Disease and the Mediterranean Diet: Insights into Sex-Specific Responses. Nutrients [Internet]. 2024 Jan 1;16(4):570. Available from: https://www.mdpi.com/2072-6643/16/4/570
  28. Ma MG, A G, M RC. The Mediterranean Diet and Cardiovascular Health [Internet]. Circulation research. 2019. Available from: https://pubmed.ncbi.nlm.nih.gov/30817261/
  29. Martínez-González MA, Gea A, Ruiz-Canela M. The Mediterranean Diet and Cardiovascular Health. Circulation Research [Internet]. 2019 Feb 28;124(5):779–98. Available from: https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.118.313348
  30. Mayo Clinic Staff. Mediterranean diet: A heart-healthy eating plan [Internet]. Mayo Clinic. 2021. Available from: https://www.mayoclinic.org/healthy-lifestyle/nutrition-and-healthy-eating/in-depth/mediterranean-diet/art-20047801
  31. Lichtenstein AH, Appel LJ, Vadiveloo M, Hu FB, Kris-Etherton PM, Rebholz CM, et al. 2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation [Internet]. 2021 Nov 2;144(23):472–87. Available from: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001031
  32. Heidemann C, Schulze MB, Franco OH, van Dam RM, Mantzoros CS, Hu FB. Dietary Patterns and Risk of Mortality From Cardiovascular Disease, Cancer, and All Causes in a Prospective Cohort of Women. Circulation [Internet]. 2008 Jul 15;118(3):230–7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2748772/
  33. Denova-Gutiérrez E, Tucker KL, Flores M, Barquera S, Salmerón J. Dietary Patterns Are Associated with Predicted Cardiovascular Disease Risk in an Urban Mexican Adult Population. The Journal of Nutrition [Internet]. 2015 Nov 18;146(1):90–7. Available from: https://academic.oup.com/jn/article/146/1/90/4616080#171778403
  34. Gardner CD, Vadiveloo MK, Petersen KS, Anderson CAM, Springfield S, Van Horn L, et al. Popular Dietary Patterns: Alignment With American Heart Association 2021 Dietary Guidance: A Scientific Statement From the American Heart Association. Circulation [Internet]. 2023 Apr 27;147(22). Available from: https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000001146
  35. American Heart Association. The american heart association’s diet and lifestyle recommendations [Internet]. American Heart Association. American Heart Association; 2024. Available from: https://www.heart.org/en/healthy-living/healthy-eating/eat-smart/nutrition-basics/aha-diet-and-lifestyle-recommendations
  36. Teicholz N. A short history of saturated fat: the making and unmaking of a scientific consensus. Current Opinion in Endocrinology, Diabetes & Obesity. 2022 Dec 8;30(1):65–71.
  37. Focus on Healthy Foods Instead of Saturated Fat Limits, Research Suggests [Internet]. CardioSmart. 2020 [cited 2025 Jul 30]. Available from: https://www.cardiosmart.org/news/2020/10/focus-on-healthy-foods-instead-of-saturated-fat-limits-research-suggests
  38. Mizuno A. There Is More Than Meets the Label: Rethinking Saturated Fat and Cardiovascular Health. JMA Journal [Internet]. 2025 Jan 1 [cited 2025 Jul 28];8(2). Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12095710/
  39. Shi F, Chowdhury R, Sofianopoulou E, Koulman A, Sun L, Marinka Steur, et al. Association of circulating fatty acids with cardiovascular disease risk: Analysis of individual-level data in three large prospective cohorts and updated meta-analysis. European Journal of Preventive Cardiology [Internet]. 2024 Oct 4 [cited 2025 Jan 16]; Available from: https://doi.org/10.1093/eurjpc/zwae315
  40. Micha R, Mozaffarian D. Saturated Fat and Cardiometabolic Risk Factors, Coronary Heart Disease, Stroke, and Diabetes: a Fresh Look at the Evidence. Lipids. 2010 Mar 31;45(10):893–905.
  41. Law HG, Munkhtuya Myagmarsuren, Bang H, Zhang W, Lefevre M, Berglund L, et al. Lipoprotein(a) Response to Dietary Saturated Fat Reduction: Relationship to Apolipoprotein(a) Size Polymorphism in African Americans. Nutrients [Internet]. 2025 Jan 24;17(3):426–6. Available from: https://www.mdpi.com/2072-6643/17/3/426
  42. Mozaffarian D. Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: a Comprehensive Review. Circulation [Internet]. 2016 Jan 8;133(2):187–225. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26746178
  43. org. 2024. Available from: https://www.eatrightpro.org/news-center/research-briefs/saturated-fat-intake-evidence-based-guideline
  44. Forouhi NG, Krauss RM, Taubes G, Willett W. Dietary fat and cardiometabolic health: evidence, controversies, and consensus for guidance. BMJ [Internet]. 2018 Jun 13;361(361):k2139. Available from: https://www.bmj.com/content/361/bmj.k2139
  45. Staudacher HM, Yao CK, Chey WD, Whelan K. Optimal Design of Clinical Trials of Dietary Interventions in Disorders of Gut-Brain Interaction. American Journal of Gastroenterology. 2022 Mar 16;117(6):973–84.
  46. Lewis JD, Albenberg L, Lee D, Kratz M, Gottlieb K, Reinisch W. The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease. Inflammatory Bowel Diseases [Internet]. 2017 Feb;23(2):181–91. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5250567/
  47. Yao CK, Gibson PR, Shepherd SJ. Design of Clinical Trials Evaluating Dietary Interventions in Patients With Functional Gastrointestinal Disorders. American Journal of Gastroenterology. 2013 May;108(5):748–58.
  48. Johnston BC, Zeraatkar D, Steen J, de Jauregui DRF, Zhu H, Sun M, et al. Saturated fat and human health: a protocol for a methodologically innovative systematic review and meta-analysis to inform public health nutrition guidelines. Systematic Reviews [Internet]. 2023 Mar 14;12(1):39. Available from: https://pubmed.ncbi.nlm.nih.gov/36918997/
  49. Chen X, Kwan MP. Contextual Uncertainties, Human Mobility, and Perceived Food Environment: The Uncertain Geographic Context Problem in Food Access Research. American Journal of Public Health. 2015 Sep;105(9):1734–7.
  50. Parvin Mirmiran, Hanieh Malmir, Zahra Bahadoran. Common Study Designs of Nutrition Clinical Trials: Review of the Basic Elements and the Pros and Cons. Journal of Biostatistics and Epidemiology. 2024 Jan 2;
  51. com [Internet]. Researchopenworld.com. 2015 [cited 2025 Jul 30]. Available from: https://researchopenworld.com/challenges-in-nutritional-clinical-research-how-can-adaptive-design-be-of-help/
  52. Worthington A, Coffey T, Gillies K, Roy R, Braakhuis A. Exploring how researchers consider nutrition trial design and participant adherence: a theory-based analysis. Frontiers in Nutrition. 2024 Dec 17;11.
  53. Weaver CM, Hodges JK. Designing, Conducting, and Documenting Human Nutrition Plant-Derived Intervention Trials. Frontiers in Nutrition. 2021 Dec 23;8.
  54. Saturated fatty acid and trans-fatty acid intake for adults and children: WHO guideline [Internet]. www.who.int. 2023. Available from: https://www.who.int/publications/i/item/9789240073630
  55. Schneeman B. Science-Based Regulatory and Policy Considerations in Nutrition. Advances in Nutrition. 2015 May 1;6(3):361S367S.